Finance

Lists
1SXP:ETR
SCHOTT Pharma AG & Co KgaA
22,35 €
+0,22%
(+0,050) 1D
13-ноя., 09:17:32 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1SXP...
Open
22,60 €
High
22,60 €
Low
22,30 €
Mkt. cap
3,37 млд
Avg. vol.
88,55 миң
Volume
1,76 миң
Dividend
0,81%
Quarterly dividend
0,05 €
Ex-dividend date
2026-ж., 4-фев.
P/E ratio
24,50
52-wk high
26,20 €
52-wk low
12,62 €
EPS
0,91 €
Shares outstanding
150,61 млн
No. of employees
5 миң
Open
22,60 €
High
22,60 €
Low
22,30 €
Mkt. cap
3,37 млд
Avg. vol.
88,55 миң
Volume
1,76 миң
Dividend
0,81%
Quarterly dividend
0,05 €
Ex-dividend date
2026-ж., 4-фев.
P/E ratio
24,50
52-wk high
26,20 €
52-wk low
12,62 €
EPS
0,91 €
Shares outstanding
150,61 млн
No. of employees
5 миң
News stories
From web sources and news partners
Profile
Schott Pharma is a provider of drug containment solutions and delivery systems for injectable drugs. Originally a division of glass manufacturer Schott AG, the company went public on the Frankfurt Stock Exchange in 2023. Headquartered in Mainz, Germany, the company operates in 14 countries. Wikipedia
About SCHOTT Pharma AG & Co KgaA
CEO-
Employees5 миң
Founded2022-ж., 1-авг.
Headquarters-
SectorHealth Care
Industry-
Last report
2026-ж., 12-авг.
Fiscal period
Q3 2026
0,26 € / 0,26 €
-1,81%miss
Revenue / Est. (EUR)
281,76 млн / 272,46 млн
+3,41%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
247,58 млн
240,19 млн
247,88 млн
281,76 млн
Cost of goods sold
171,50 млн
160,44 млн
172,78 млн
195,38 млн
Cost of revenue
171,50 млн
160,44 млн
172,78 млн
195,38 млн
Research and development expenses
6,36 млн
7,34 млн
6,05 млн
6,34 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
32,89 млн
33,73 млн
32,51 млн
35,30 млн
Operating expense
35,95 млн
40,70 млн
35,55 млн
37,48 млн
Total operating expenses
207,45 млн
201,14 млн
208,33 млн
232,86 млн
Operating income
40,14 млн
39,05 млн
39,55 млн
48,90 млн
Other non operating income
-61,00 миң
-79,00 миң
-212,00 миң
-116,00 миң
EBT including unusual items
41,76 млн
42,04 млн
40,31 млн
51,23 млн
EBT excluding unusual items
41,02 млн
42,04 млн
40,31 млн
51,23 млн
Income tax expense
8,09 млн
8,76 млн
9,17 млн
12,25 млн
Effective tax rate
19,37%
20,84%
22,76%
23,91%
Other operating expenses
-3,30 млн
-366,00 миң
-3,01 млн
-4,16 млн
Net income
33,56 млн
33,18 млн
31,01 млн
38,83 млн
Net profit margin
13,55%
13,81%
12,51%
13,78%
Earnings per share
0,22
0,22
0,21
0,26
Interest and investment income
2,02 млн
2,33 млн
1,84 млн
1,96 млн
Interest expense
-4,71 млн
-4,00 млн
-4,01 млн
-3,87 млн
Net interest expenses
-2,69 млн
-1,67 млн
-2,16 млн
-1,91 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
56,70 млн
60,46 млн
61,41 млн
71,14 млн
Gain or loss from assets sale
-88,00 миң
-48,00 миң
-72,00 миң
48,00 миң
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору